Inactive Instrument

BioLight Life Sciences Ltd Stock TEL AVIV STOCK EXCHANGE

Equities

IL0010952237

Advanced Medical Equipment & Technology

Financials

Sales 2022 63K 16.74K 6.3M Sales 2023 118K 31.35K 11.8M Capitalization 24.12M 6.41M 2.41B
Net income 2022 -7M -1.86M -700M Net income 2023 -26M -6.91M -2.6B EV / Sales 2022 207 x
Net cash position 2022 17.1M 4.54M 1.71B Net cash position 2023 8.55M 2.27M 855M EV / Sales 2023 132 x
P/E ratio 2022
-3.85 x
P/E ratio 2023
-0.93 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 43.16%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 54 20-04-30
Director of Finance/CFO 48 15-04-30
Chief Tech/Sci/R&D Officer 69 19-11-30
Members of the board TitleAgeSince
Chairman 84 11-04-20
Director/Board Member 71 17-05-10
Director/Board Member 50 20-03-24
More insiders
Biolight Life Sciences Ltd, formerly Bio Light Israeli Life Sciences Investments Ltd, is an Israel-based company engaged, through its subsidiaries, in various fields of research and development of pharmaceuticals and medical products and devices. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The Company provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.
More about the company